Patrick Innamarato

5PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.

MacLean S Hall, John E Mullinax, Cheryl A Cox

|May 02, 2022
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.

Alexandra L Martin, Carmen M Anadon, Subir Biswas

|Dec 24, 2021
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer.

Gunjan Mandal, Subir Biswas, Carmen M Anadon

|Dec 11, 2020
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo.

Brittany L Bunch, Jennifer Morse, Sarah Asby

|Oct 06, 2020
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells.

Patrick Innamarato, Sarah Asby, Jennifer Morse

Pageof 1